The United Laboratories International Holdings (ULIHF) AI Stock Analysis
The United Laboratories International Holdings
(Other OTC:ULIHF)
No summary available
The United Laboratories International Holdings (ULIHF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.86B
- Dividend Yield
- 4.37%
- Average Volume (3M)
- 1,007
- Price to Earnings (P/E)
- 20.8
- Beta (1Y)
- -0.28
- Revenue Growth
- -13.11%
- EPS Growth
- -83.15%
- Country
- US
- Employees
- 18,000
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
The United Laboratories International Holdings Business Overview & Revenue Model
Company Description
The United Laboratories International Holdings Limited functions as an investment holding company with a primary focus on the pharmaceutical sector. Its multifaceted operations cover the entire lifecycle of drug development and commercialization, fro...
The United Laboratories International Holdings Peers Comparison
Overall Rating
HK:168187Outperform
HK:151377Outperform
HK:332068Neutral
HK:051267Neutral
HK:086761Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1681 | 87Outperform | HKD 12.54B | 9.38 | 25.10% | 5.11% | 15.05% | 20.58% |
| HK:1513 | 77Outperform | HKD 26.72B | 16.30 | 11.32% | 6.71% | -9.56% | -23.22% |
| HK:3320 | 68Neutral | HKD 29.12B | 6.18 | 7.92% | 5.17% | 7.94% | 52.83% |
| HK:0512 | 67Neutral | HKD 15.30B | 13.45 | 6.61% | 3.92% | 7.35% | -45.49% |
| HK:0867 | 61Neutral | HKD 23.94B | 13.43 | 8.60% | 3.50% | 14.80% | -2.88% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ULIHF | The United Laboratories International | 0.87 | -0.94 | -51.90% | |
| HK:0867 | China Medical System Holdings | 9.81 | -3.65 | -27.10% | |
| HK:1513 | Livzon Pharmaceutical Group Class H | 23.18 | -5.02 | -17.81% | |
| HK:3320 | China Resources Pharmaceutical Group Ltd. | 4.63 | -0.11 | -2.26% | |
| HK:1681 | Consun Pharmaceutical Group Ltd. | 15.25 | 1.00 | 7.00% | |
| HK:0512 | Grand Pharmaceutical Group Limited | 4.31 | -4.18 | -49.26% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.